Search results
- 0.9290Add to watchlist-0.0560 (-5.69%)At close:4:00 PM EDTMon. May 20, 20240.9201 -0.01 (-0.96%)After hrs:7:12 PM EDTMon. May 20, 2024Nasdaq Real Time Price (USD) · Market closed
- Open0.9600High0.9603Low0.9200
- Mkt Cap3.53MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.985052 Wk. Low0.500052 Wk. High8.6000
Related stocks
6 days ago · Get a real-time INVO Bioscience, Inc. (INVO) stock price quote with breaking news, financials, statistics, charts and more.
- 1.99M
- 3.02M
- 8.03M
- 1.09M
3 days ago · Invo BioScience (INVO) (Delayed Data from NSDQ) $0.99 USD. -0.02 (-1.50%) Updated May 17, 2024 04:00 PM ET. After-Market: $0.98 -0.01 (-0.51%) 7:58 PM ET. Add to portfolio. Zacks Rank: Style...
6 days ago · "We are pleased with the progress we have made at INVO, reporting record first quarter 2024 revenue with growth of 353% compared to the first quarter of 2023, and a substantial $1.2 million ...
People also ask
What does INVO stand for?
How has INVO performed in the first quarter 2024?
Where can I buy INVO stock?
How has INVO Bioscience Inc (INVO) stock performed in the past year?
5 days ago · INVO Bioscience's stock was trading at $1.35 at the beginning of 2024. Since then, INVO shares have decreased by 25.2% and is now trading at $1.0099. View the best growth stocks for 2024 here .
- info@invobio.com
- 25
5 days ago · INVO Reports Record First Quarter 2024 Financial Results. 353% Revenue Growth with improvement in Adjusted EBITDA. May 15, 2024 16:15 ET | Source: INVO Bioscience. Follow. SARASOTA, Fla., May...
5 days ago · Management Commentary. "We are pleased with the progress we have made at INVO, reporting record first quarter 2024 revenue with growth of 353% compared to the first quarter of 2023, and a substantial $1.2 million improvement in our adjusted EBITDA,” commented Steve Shum, CEO of INVO.
4 days ago · INVO Bioscience Stock (NASDAQ:INVO), Quotes and News Summary - Benzinga. (NASDAQ:INVO) Intraday. $1.15. 0.08[7.48%] 15 minutes delayed. Why is it moving? INNO BioScience shares are trading...